Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
SV95C is approved by EMA as the digital primary endpoint for DMD trials
Source – Sysnav Healthcare The European Medicines Agency (EMA) has granted approval for the utilization of a digital measurement employing ...
How Mounjaro Boosted Eli Lilly’s Sales and Fought Obesity
As Eli Lilly’s flagship diabetes medication, Mounjaro, continues its meteoric rise in popularity and edges closer to potential approval for ...
Sotyktu, a campaign by Bristol Myers Squibb to provide “clear understanding” of living with psoriasis, launches
Source – Bristol Myers Squibb Bristol Myers Squibb is striving to provide a comprehensive insight into the challenges of living ...
leading obesity medication Wegovy’s ‘best-case scenario’ Novo Nordisk published cardiac results statistics
Source – Novo Nordisk Novo Nordisk has been capitalizing on the momentum generated by its weight loss drug, Wegovy, which ...
What’s Behind Emergent BioSolutions’ Decision to Lay Off 400 Employees and Eliminate an Executive Role?
Emergent BioSolutions is undergoing substantial changes as it shifts its focus away from its challenged contract development and manufacturing organization ...
Mirati fires its CEO and announces a new lung cancer Krazati-Keytruda study strategy
Following the successful approval of the KRAS inhibitor Krazati, Mirati Therapeutics’ CEO David Meek has made an abrupt exit from ...
How Remibrutinib, a Novartis Drug, Can Heal Your Hives
Source – Novartis Novartis has unveiled promising initial outcomes from the Phase III REMIX-1 and REMIX-2 trials assessing the effectiveness ...
Intra-Cellular Therapies Elevates Caplyta’s Impact with ‘Let in the Lyte’ Campaign
In a strategic move fueled by its triumph in the Fierce Madness Drug Ad Tournament, Intra-Cellular Therapies is significantly enhancing ...
UK establishes ‘100-day’ rapid-response vaccination unit
The UK government has formally inaugurated an advanced vaccine research center situated within the UK Health and Security Agency (UKHSA) ...
UK Biotech Sector Thrives with Record venture capital Funding in Q2
In the face of an economic downturn, the second quarter of the year saw a robust influx of new financing ...
GSK signals a marketing pause in Nigeria after taking the same action in Kenya and India
Last week, GSK announced its intention to discontinue the commercialization of its prescription drugs and vaccines in Nigeria, planning to ...
Revolutionizing Biologics Manufacturing with $490M Partnership: Merck and Ginkgo Bioworks Join Forces
Source – Ginkgo Bioworks As part of this agreement, Ginkgo will contribute its expertise in cell engineering, ultra-high-throughput multiplexed screening, ...
Apogee Doses First Patients in Phase I Trial of APG777
Source – Apogee Therapeutics Apogee Therapeutics has embarked on a significant milestone by commencing the dosing of healthy volunteers in ...
Daiichi Sankyo to Dominate Antibody-Drug Conjugates Market by 2029
Daiichi has successfully established ADCs (Antibody-Drug Conjugates) as a significant therapeutic approach, overcoming previous years of underwhelming results. Even though ...
PFS in Patients with Platinum-Resistant Ovarian Cancer Is Not Improved by Batiraxcept
Source – Aravive The Phase III AXLerate-OC trial (NCT04300140) assessing the combination of batiraxcept with paclitaxel has not met its ...
Astellas Buys $50M Stake in Poseida, Boosting Gene Therapy Pipeline
Source – Poseida Therapeutics Japanese pharmaceutical company Astellas is making a strategic move by investing $50 million to acquire an ...
How Vistagen’s Nasal Spray for Social Anxiety Boosted Its Stock by 1,272%
Source – Vistagen Therapeutics After facing a string of setbacks, Vistagen has experienced a remarkable turnaround as its social anxiety ...
Bavarian Nordic’s Chikungunya Vaccine Shines in Phase III Trials, Poses Strong Challenge to Valneva’s Dominance
Source – Bavarian Nordic Bavarian Nordic has achieved a significant milestone with its chikungunya virus vaccine candidate, marking its second ...
Novartis Invests $60 Million Upfront in Ionis’ Innovative Cardiovascular Medication
Source – Ionis Pharmaceuticals Novartis has enlisted Ionis to develop another drug for cardiovascular disease, investing $60 million in a ...
GSK researchers discover a novel method to combat malaria
Source – GSK Researchers at GSK have made a remarkable discovery in the battle against malaria, and it’s not a ...
Beyfortus: A Breakthrough RSV Shot for Infants Approved by CDC
Source – Sanofi The US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has given ...
Soft Tissue Sarcoma: Symptoms, Types, Causes, Treatment and Future Directions
What is Soft Tissue Sarcoma? Vascular tumors are a type of soft tissue sarcoma that can affect the blood vessels ...
Voxzogo Demand Outstrips Supply: BioMarin’s Growth Dilemma
BioMarin is facing challenges due to the overwhelming success of its drug, Voxzogo, used to treat achondroplasia, a type of ...
J&J Influencers Urge Parents to Check Kids’ Eyes
Johnson & Johnson (J&J) is launching a targeted marketing campaign for its recently FDA-approved overnight contact lenses, Acuvue Abiliti, to ...
Vaginal Cancer: A Comprehensive Guide to Symptoms, Types, Causes, Treatment and More
Vaginal cancer is a rare but serious condition that affects the muscular tube that connects your uterus with your outer ...
How Skyrizi Outspent Other Drugs in a Tough Market
In July, AbbVie’s Skyrizi maintained its position as the top pharma drug ad spender for the second consecutive month, but ...
Lilly’s Retevmo Outperforms Gavreto in Lung Cancer Study
Source – Eli Lilly In the ongoing rivalry between Eli Lilly and Blueprint Medicines over their RET inhibitors, Eli Lilly ...
Galapagos Drops Jyseleca in Europe, Lowers Sales Outlook
Galapagos has suffered a significant setback as it decided not to submit a Marketing Authorization Application (MAA) for its drug ...
FDA Approves Zurzuvae: A Game-Changer for Postpartum
Source – Biogen Biogen and Sage Therapeutics have received FDA approval for Zurzuvae (zuranolone) 50 mg, a breakthrough treatment for ...
FDA Approves Izervay for Geographic Atrophy
Source – Astellas Pharma Astellas Pharma has received FDA approval for Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic ...
